| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Jul―01 |
Cytokine Signatures and Immune Dysregulation in COVID-19 Patients: Transcriptomic and Serum Analysis |
Nikola Ralchev, Silviya Lyubenova Bradyanova, Yana Valerieva Doneva, Nikolina Mihaylova, Elena Vikentieva Elefterova-Florova, Andrey Ivanov Tchorbanov, et al. (+4) José Francisco Muñoz-Valle, Maria Cristina Petralia, Ferdinando Nicoletti, Paolo Fagone |
| 2 |
[GO] |
2024―May―13 |
The Effects of Convalescent Plasma Transfusion on Serum Levels of Macrophage-Associated Inflammatory Biomarkers in Patients with Severe COVID-19 |
Mojtaba Shohan, Mohammad Reza Mahmoudian-Sani, Ali Saeedi-Boroujeni, Sara Iranparast, Roohangiz Nashibi, Farhad Abolnezhadian, et al. (+4) Farid Yousefi, Seyed Mohammad Alavi, Bahman Cheraghian, Ali Khodadadi |
| 3 |
[GO] |
2024―Apr―10 |
Pharmacodynamic of Recombinant Human Interferon Alpha-2b Nasal Drops and Effective Prophylaxis Against SARS-COV-2 Infection |
Hugo Nodarse-Cuni, Odalys Bravo, Roberto Cañete, Dania Vázquez-Blomquist, Diogenes Quintana, Ana Aguilera-Barreto, et al. (+3) Gerardo Guillen-Nieto, Amaylid Arteaga, Ileana Morales |
| 4 |
[GO] |
2024―Apr―01 |
The Effective Inhibitory Concentration of Interferon-β Correlates with Infectivity and Replication Fitness of SARS-CoV-2 Variants |
Janmejay Singh, Anbalagan Anantharaj, Parveen Kumar, Rajesh Pandey, Anil Kumar Pandey, Guruprasad R. Medigeshi |
| 5 |
[GO] |
2023―Dec―28 |
Association of Polymorphisms of the IL-17A and IL-17F Genes with Increased Risk of Hypertension and Obesity in Mexican Patients with COVID-19 |
Richard Salama-Frisbie, Cinthia A. Molina-Flores, Arguiñe I. Urraza-Robledo, María E. Gutiérrez-Pérez, Alberto A. Miranda-Pérez, Alhi A. Gutiérrez-Salas, et al. (+2) Jorge Haro-Santa Cruz, Francisco C. López-Márquez |
| 6 |
[GO] |
2023―Dec―04 |
BioHabana 2022: Preventive and Immunotherapeutic Strategies Against COVID-19 and Cancer in Cuba |
Iraldo Bello-Rivero, Tania Crombet-Ramos, Circe Mesa-Pardillo, Yanelys Morera-Díaz, Zaima Mazorra-Herrera, Dagmar Garcia-Rivera, et al. (+7) Hugo Nodarse-Cuní, Francisco Hernández-Bernal, Verena Muzio-Gonzalez, Ana Aguilera-Barreto, Dania Vazquez-Blomquist, Maria del Carmen Domínguez-Horta, Gerardo Guillen-Nieto |
| 7 |
[GO] |
2023―Oct―31 |
High Anti-Interferon-Alpha Autoantibody Levels in Severe/Critical COVID-19 Patients from Peru |
Maria J. Pons, Ana Mayanga-Herrera, Luciano A. Palomino-Kobayashi, Antonio M. Quispe, Manuel F. Ugarte-Gil |
| 8 |
[GO] |
2023―Sep―14 |
Characterization of IL-10 Family of Cytokines in Acute and Convalescent COVID-19 Individuals |
Anuradha Rajamanickam, Pavan Kumar Nathella, Nandhini Selvaraj, Murhekar Manoj, Jeromie Wesley Vivian Thangaraj, Santhosh Kumar Muthusamy, et al. (+6) Girish Kumar Chethrapilly Purushothaman, Tarun Bhatnagar, Manickam Ponnaiah, Sabarinathan Ramasamy, Saravanakumar Velusamy, Subash Babu |
| 9 |
[GO] |
2023―Aug―11 |
Correction to: A Specific Pattern and Dynamics of Circulating Cytokines Are Associated with the Extension of Lung Injury and Mortality in Colombian Adults with Coronavirus Disease-19, by Sara Bolívar-Marín, et al. J Interferon Cytokine Res 2023; (vol. 43, no. 5; 206-215); doi: 10.1089/jir.2023.0001 |
|
| 10 |
[GO] |
2023―Jun―29 |
Altered Tumor Necrosis Factor Response in Neurologic Postacute SARS-CoV-2 Syndrome |
Lao-Tzu Allan-Blitz, Jesse Goodrich, Howard Hu, Omid Akbari, Jeffrey D. Klausner |
| 11 |
[GO] |
2023―May―30 |
COVID-19 Severity Shifts the Cytokine Milieu Toward a Proinflammatory State in Egyptian Patients: A Cross-Sectional Study |
Mohamed L. Salem, Madonna M. Eltoukhy, Rasha E. Shalaby, Kamal M. Okasha, Mohamed R. El-Shanshoury, Mohamed A. Attia, et al. (+3) Mohamed S. Hantera, Asmaa Hilal, Mohammed A. Eid |
| 12 |
[GO] |
2023―May―30 |
Autoantibodies Neutralizing Type III Interferons Are Uncommon in Patients with Severe Coronavirus Disease 2019 Pneumonia |
Martti Vanker, Karita Särekannu, Arnaud Fekkar, Sofie Eg Jørgensen, Liis Haljasmägi, Anne Kallaste, et al. (+15) Kalle Kisand, Margus Lember, Pärt Peterson, Madhvi Menon, Tracy Hussell, Sean Knight, James Moore-Stanley, Paul Bastard, Shen-Ying Zhang, Trine H. Mogensen, Quentin Philippot, Qian Zhang, Anne Puel, Jean-Laurent Casanova, Kai Kisand |
| 13 |
[GO] |
2023―Apr―27 |
A Specific Pattern and Dynamics of Circulating Cytokines Are Associated with the Extension of Lung Injury and Mortality in Colombian Adults with Coronavirus Disease-19 |
Sara Bolívar-Marín, Marcela Castro, Diego Losada-Floriano, Santiago Cortés, Federico Perdomo-Celis, Giovani Lastra, Carlos F. Narváez |
| 14 |
[GO] |
2023―Apr―17 |
The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical) |
Mina Ghofrani Nezhad, Giti Jami, Omid Kooshkaki, Sajjad Chamani, Ali Naghizadeh |
| 15 |
[GO] |
2023―Feb―16 |
The Role of Interferons in Long Covid Infection |
Mohammad Karbalaeimahdi, Safar Farajnia, Nasrin Bargahi, Farzaneh Ghadiri-Moghaddam, Hamid Reza Rasouli Jazi, Nasim Bakhtiari, et al. (+2) Samaneh Ghasemali, Nosratollah Zarghami |
| 16 |
[GO] |
2022―Dec―01 |
Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence |
Thomas Hach, Kasra Shakeri-Nejad, Marc Bigaud, Frank Dahlke, Massimiliano de Micco, Olivier Petricoul, et al. (+5) Gordon Graham, Daniela Piani-Meier, Renato Turrini, Volker Brinkmann, Ferdinando Nicoletti |
| 17 |
[GO] |
2022―Sep―30 |
Can the Prognosis of COVID-19 Disease Be Determined by Fecal Markers and Cytokines? |
Ahsen Dönmez Türkmen, Gülçin Ünlü, Gulustan Musayeva, Erkan Akkuş, Aybüke Gurup Özen, Pınar Önal, et al. (+6) Mert Kuşkucu, Kenan Midilli, Ayse Ayzıt Kılınç, Haluk Çokuğraş, Fügen Çullu Çokuğraş, Ömer Faruk Beşer |
| 18 |
[GO] |
2022―Aug―19 |
The Role of Inflammasomes in COVID-19: Potential Therapeutic Targets |
Chen Sun, Hangyuan Zhao, Yunze Han, Yiqing Wang, Xiao Sun |
| 19 |
[GO] |
2022―Aug―12 |
Analysis of Chitinase-3-Like Protein 1, IL-1-Alpha, and IL-6 as Novel Inflammatory Biomarkers for COVID-19 |
Emine Parlak, Esra Laloğlu |
| 20 |
[GO] |
2022―Jun―16 |
Differential Leukocyte Expression of IFITM1 and IFITM3 in Patients with Severe Pandemic Influenza A(H1N1) and COVID-19 |
Nora E. Regino-Zamarripa, Gustavo Ramírez-Martínez, Luis Armando Jiménez-Álvarez, Alfredo Cruz-Lagunas, Itzel Alejandra Gómez-García, Sergio Ignacio-Cortés, et al. (+13) José Eduardo Márquez-García, Lynette Miroslava Pacheco-Hernández, Jazmín Ariadna Ramírez-Noyola, Rodrigo Barquera, Criselda Mendoza-Milla, Cesar Luna-Rivero, José Guillermo Domínguez-Cherit, Remedios Ramírez-Rangel, Tatiana Sofía Rodríguez-Reyna, Carmen M. Hernández-Cárdenas, José Alberto Choreño-Parra, Gloria León-Ávila, Joaquín Zúñiga |
| 21 |
[GO] |
2022―Jun―08 |
Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza |
Lynette Miroslava Pacheco-Hernández, Jazmín Ariadna Ramírez-Noyola, Itzel Alejandra Gómez-García, Sergio Ignacio-Cortés, Joaquín Zúñiga, José Alberto Choreño-Parra |
| 22 |
[GO] |
2022―Jun―08 |
Emergency Hematopoiesis in the Pathobiology of COVID-19: The Dark Side of an Early Innate Protective Mechanism |
Juan Carlos Balandrán, Gabriela Zamora-Herrera, Rubí Romo-Rodríguez, Rosana Pelayo |
| 23 |
[GO] |
2022―Jun―01 |
Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae |
Gustavo Ramírez-Martínez, Luis Armando Jiménez-Álvarez, Alfredo Cruz-Lagunas, Sergio Ignacio-Cortés, Itzel Alejandra Gómez-García, Tatiana Sofia Rodríguez-Reyna, et al. (+2) José Alberto Choreño-Parra, Joaquín Zúñiga |
| 24 |
[GO] |
2022―May―13 |
Levels of Vascular Endothelial Growth Factor and Its Association with Pulmonary Embolism in COVID-19 |
Jazmin A. Guerra-López, Luis M. Amezcua-Castillo, Héctor González-Pacheco, Luis M. Amezcua-Guerra |
| 25 |
[GO] |
2021―Dec―22 |
Cutting-Edge Research in COVID-19 and General Viral Immunology |
Paul G. Thomas, Katherine Kedzierska |
| 26 |
[GO] |
2021―Nov―17 |
The Impact of IFNλ4 on the Adaptive Immune Response to SARS-CoV-2 Infection |
Michelle Møhlenberg, Ida Monrad, Line K. Vibholm, Stine S.F. Nielsen, Giacomo Schmidt Frattari, Mariane Høgsbjerg Schleimann, et al. (+7) Rikke Olesen, Mads Kjolby, Jesper Damsgaard Gunst, Ole Schmeltz Søgaard, Thomas R. O'Brien, Martin Tolstrup, Rune Hartmann |
| 27 |
[GO] |
2021―Jul―19 |
Quantitative Insight into Immunopathology of SARS-CoV-2 Infection |
Bhavnita Soni, Ritika Kabra, Shailza Singh |
| 28 |
[GO] |
2021―Jun―23 |
Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses |
Thomas Kehrer, Adolfo García-Sastre, Lisa Miorin |
| 29 |
[GO] |
2021―Apr―22 |
Linkage of Lambda Interferons in Protection Against Severe COVID-19 |
Mehdi Shahbazi, Parviz Amri Maleh, Mojgan Bagherzadeh, Zahra Moulana, Mahdi Sepidarkish, Maryam Rezanejad, et al. (+7) Mohammad Mirzakhani, Soheil Ebrahimpour, Hosein Ghorbani, Zahra Ahmadnia, Mostafa Javanian, Masomeh bayani, Mousa Mohammadnia-Afrouzi |
| 30 |
[GO] |
2021―Feb―23 |
Perspectives on Targeting IL-6 as a Potential Therapeutic Strategy for COVID-19 |
Yordan Khaedir, Rona Kartika |
| 31 |
[GO] |
2020―Dec―18 |
Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review |
Benjamin M. Liu, Harry R. Hill |
| 32 |
[GO] |
2020―Dec―18 |
Therapeutic Effectiveness of Interferon Alpha 2b Treatment for COVID-19 Patient Recovery |
Ricardo Pereda, Daniel González, Hubert Blas Rivero, Juan Carlos Rivero, Albadio Pérez, Lissette Del Rosario Lopez, et al. (+5) Natacha Mezquia, Rafael Venegas, Julio Roberto Betancourt, Rodolfo Emilio Domínguez, Hugo Nodarse |
| 33 |
[GO] |
2020―Dec―18 |
Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2 |
Hongjie Xia, Pei-Yong Shi |
| 34 |
[GO] |
2020―Sep―22 |
Therapeutic Effectiveness of Interferon-α2b Against COVID-19: The Cuban Experience |
Ricardo Pereda, Daniel González, Hubert Blas Rivero, Juan Carlos Rivero, Albadio Pérez, Lissette Del Rosario López, et al. (+4) Natacha Mezquia, Rafael Venegas, Julio Roberto Betancourt, Rodolfo Emilio Domínguez |
| 35 |
[GO] |
2020―Sep―03 |
Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin |
Urooj Fatima, Syed Saif Abbas Rizvi, Saher Fatima, Md. Imtaiyaz Hassan |
| 36 |
[GO] |
2020―Aug―13 |
A Geroscience Approach to Preventing Pathologic Consequences of COVID-19 |
Yan Dou, Soroosh Fatemi, Martin Darvas, Michael Gale, Warren Ladiges |
| 37 |
[GO] |
2020―Aug―03 |
COVID-19, Mitochondria, and Interferon |
Pankaj Prasun |
|
